Binbin Cui

449 total citations
20 papers, 340 citations indexed

About

Binbin Cui is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Binbin Cui has authored 20 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Binbin Cui's work include Cancer, Lipids, and Metabolism (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Cells and Metastasis (3 papers). Binbin Cui is often cited by papers focused on Cancer, Lipids, and Metabolism (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Cells and Metastasis (3 papers). Binbin Cui collaborates with scholars based in China and United States. Binbin Cui's co-authors include Yanlong Liu, Yanmei Yang, Shougang Zhuang, Peng Han, Tao Ji, Yongmin Li, Xinshu Dong, Yupeng Liu, Xiaojuan Zhao and Na Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinica Chimica Acta.

In The Last Decade

Binbin Cui

19 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Binbin Cui China	12	197	123	87	56	34	20	340
Weiying Li China	11	143 0.7×	106 0.9×	126 1.4×	97 1.7×	31 0.9×	29	363
Maopeng Yang China	9	312 1.6×	226 1.8×	136 1.6×	82 1.5×	19 0.6×	16	486
Dandan Yin China	12	272 1.4×	119 1.0×	85 1.0×	17 0.3×	23 0.7×	29	433
Hiromichi Nagano Japan	8	228 1.2×	67 0.5×	74 0.9×	43 0.8×	13 0.4×	9	426
Primitiva Menéndez Spain	6	259 1.3×	199 1.6×	55 0.6×	41 0.7×	12 0.4×	11	357
Alexander Bank United States	7	209 1.1×	55 0.4×	113 1.3×	30 0.5×	15 0.4×	11	337
Kaori Yuuki Japan	7	330 1.7×	118 1.0×	68 0.8×	49 0.9×	6 0.2×	10	381
Chunjuan Zhao China	9	257 1.3×	194 1.6×	46 0.5×	44 0.8×	5 0.1×	12	360
Gaëlle Tilman Belgium	9	277 1.4×	39 0.3×	70 0.8×	18 0.3×	13 0.4×	16	453
Ranran Kong China	14	331 1.7×	189 1.5×	107 1.2×	67 1.2×	5 0.1×	37	445

Countries citing papers authored by Binbin Cui

Since Specialization

Citations

This map shows the geographic impact of Binbin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binbin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binbin Cui more than expected).

Fields of papers citing papers by Binbin Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binbin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binbin Cui. The network helps show where Binbin Cui may publish in the future.

Co-authorship network of co-authors of Binbin Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Binbin Cui. A scholar is included among the top collaborators of Binbin Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binbin Cui. Binbin Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Jinzhu, Hairong Jiang, Binbin Cui, et al.. (2025). Polynorepinephrine nanoagent enables targeted mitochondrial delivery for enhanced tumor therapy through ferroptosis. Colloids and Surfaces B Biointerfaces. 257. 115193–115193.

Cui, Binbin, Chao Yu, Shenglei Zhang, et al.. (2022). Delayed Administration of Nintedanib Ameliorates Fibrosis Progression in CG-Induced Peritoneal Fibrosis Mouse Model. SHILAP Revista de lepidopterología. 8(4). 319–333. 6 indexed citations

Zeng, Furong, Huiyan Sun, Yanlong Liu, et al.. (2022). Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients. Bioengineered. 13(2). 2498–2512. 38 indexed citations

Shi, Yingfeng, Yan Hu, Binbin Cui, Shougang Zhuang, & Na Liu. (2021). Vascular endothelial growth factor-mediated peritoneal neoangiogenesis in peritoneal dialysis. Peritoneal Dialysis International. 42(1). 25–38. 17 indexed citations

Liu, Feng, Chao Yu, Shenglei Zhang, et al.. (2021). Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial‐to‐mesenchymal transition, inflammation and angiogenesis. Journal of Cellular and Molecular Medicine. 25(13). 6103–6114. 19 indexed citations

Ma, Xiaoyan, Min Tao, Yan Hu, et al.. (2021). Clinical outcomes, quality of life, and costs evaluation of peritoneal dialysis management models in Shanghai Songjiang District: a multi-center and prospective cohort study. Renal Failure. 43(1). 754–765. 1 indexed citations

Liu, Feng, Wang Li, Fang Lü, et al.. (2020). Synergistic Inhibition of Renal Fibrosis by Nintedanib and Gefitinib in a Murine Model of Obstructive Nephropathy. SHILAP Revista de lepidopterología. 7(1). 34–49. 24 indexed citations

Yang, Kai, Fan Zhang, Peng Han, et al.. (2018). Metabolomics approach for predicting response to neoadjuvant chemotherapy for colorectal cancer. Metabolomics. 14(9). 110–110. 24 indexed citations

Deng, Kui, Peng Han, Wei Song, et al.. (2018). Plasma metabolomic profiling distinguishes right-sided from left-sided colon cancer. Clinica Chimica Acta. 487. 357–362. 21 indexed citations

10.

Li, Yongmin, Jingwen Li, Liu He, Yanlong Liu, & Binbin Cui. (2017). Expression of MYSM1 is associated with tumor progression in colorectal cancer. PLoS ONE. 12(5). e0177235–e0177235. 9 indexed citations

11.

Li, Yongmin, et al.. (2017). USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4. Oncotarget. 8(20). 32683–32695. 29 indexed citations

12.

Li, Li, Yongmin Li, Ping Zhou, et al.. (2016). Abnormal expression of p190RhoGAP in colorectal cancer patients with poor survival.. PubMed. 8(10). 4405–4414. 8 indexed citations

13.

Liu, Xin, Mingqi Li, Dongwei Zhang, et al.. (2016). EphB6 overexpression and Apc mutation together promote colorectal cancer. Oncotarget. 7(21). 31111–31121. 26 indexed citations

14.

Wang, Tianzhen, Peng Han, Yan He, et al.. (2015). Lin28A enhances chemosensitivity of colon cancer cells to 5-FU by promoting apoptosis in a let-7 independent manner. Tumor Biology. 37(6). 7657–7665. 17 indexed citations

15.

Chen, Wangyang, Xiaojuan Zhao, Fulan Hu, et al.. (2015). The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.. PubMed. 8(6). 7092–101. 42 indexed citations

16.

Zhang, Zhiyong, Binbin Cui, Jian‐Feng Mao, et al.. (2014). Novel polymorphic EST-derived microsatellite markers for the red-listed five needle pine, Pinus dabeshanensis. Conservation Genetics Resources. 7(1). 191–192. 8 indexed citations

17.

Ji, Tao, et al.. (2014). Expression and clinicopathological significance of Mel-18 mRNA in colorectal cancer. Tumor Biology. 35(10). 9619–9625. 5 indexed citations

18.

Lan, Huanrong, Ketao Jin, Bojian Xie, et al.. (2012). Heterogeneity between primary colon carcinoma and paired lymphatic and hepatic metastases. Molecular Medicine Reports. 6(5). 1057–1068. 8 indexed citations

19.

Jin, Ketao, Guangliang Li, Binbin Cui, et al.. (2011). Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases. PLoS ONE. 6(12). e28384–e28384. 24 indexed citations

20.

Cui, Binbin, Tao Ji, & Yanmei Yang. (2011). Studies on the Expression Patterns of Class I PI3K Catalytic Subunits and Its Prognostic Significance in Colorectal Cancer. Cell Biochemistry and Biophysics. 62(1). 47–54. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact